Stocks Articles

中国创新药崛起之路

中国生物医药产业历经十年跨越发展,在后疫情时代的全球经济放缓与资本市场回调的多重压力下,正经历显著挑...

01 Dec 2025  |   35 

厚积薄发: 期权轮盘策略的致胜心法

引言 在当今瞬息万变的经济环境中,市场波动加剧,投资者往往错失获利良机。事实上,即便是选择较为稳健...

27 Nov 2025  |   52 

夜鹰先行,晨鸟先机:延长交易时段指南

引言 延长交易时段是指在正常交易时间之外进行证券买卖。与标准交易时段不同,这类交易主要通过电子...

25 Nov 2025  |   82 

一级市场与二级市场: 从认购到交易,看懂资本流动

从“开公司”到“买股票”:钱是怎么“动”起来的 想象你和朋友开了一家咖啡馆。 最初,你们投入...

19 Nov 2025  |   145 

稳定股 vs 成长股,哪种更适合你? 一次看懂差别,打造属于你的投资组合

每个投资人心里,都有两把小声音   你是不是也这样纠结过: 「我想稳稳获...

19 Nov 2025  |   88 

通货膨胀对股价有什么影响?从超市到股市,读懂通胀下的投资信号

通胀不只是超市里的价格标签   当你推着购物车走进超市时,是不是发现牛奶、面包...

19 Nov 2025  |   45 

股票回购: 公司为什么要花钱买回自己的股票?

揭开资本运作背后的信号与策略 在股市里,你可能听过这样的新闻: “苹果宣布再度回购900亿美...

14 Nov 2025  |   190 

从“烧钱”到“反内卷”,一场外卖大战引发的思考

2025年,中国外卖市场再掀风波。虽然7月18日,在中国国家市场监管局和国家网信办等部门约谈了美团(...

09 Oct 2025  |   179 

Get Started Today

Open an Account Enquiry

For assistance, call 6212 1818 | Visit our Phillip Investor Centres

联系我们开设账户

需要帮助吗?请分享您的详细资料,我们会给您答复。

IMPORTANT INFORMATION

This material is provided by Phillip Capital Management (S) Ltd (“PCM”) for general information only and does not constitute a recommendation, an offer to sell, or a solicitation of any offer to invest in any of the exchange-traded fund (“ETF”) or the unit trust (“Products”) mentioned herein. It does not have any regard to your specific investment objectives, financial situation and any of your particular needs. You should read the Prospectus and the accompanying Product Highlights Sheet (“PHS”) for key features, key risks and other important information of the Products and obtain advice from a financial adviser (“FA“) pursuant to a separate engagement before making a commitment to invest in the Products. In the event that you choose not to obtain advice from a FA, you should assess whether the Products are suitable for you before proceeding to invest. A copy of the Prospectus and PHS are available from PCM, any of its Participating Dealers (“PDs“) for the ETF, or any of its authorised distributors for the unit trust managed by PCM.  

An ETF is not like a typical unit trust as the units of the ETF (the “Units“) are to be listed and traded like any share on the Singapore Exchange Securities Trading Limited (“SGX-ST”). Listing on the SGX-ST does not guarantee a liquid market for the Units which may be traded at prices above or below its NAV or may be suspended or delisted. Investors may buy or sell the Units on SGX-ST when it is listed. Investors cannot create or redeem Units directly with PCM and have no rights to request PCM to redeem or purchase their Units. Creation and redemption of Units are through PDs if investors are clients of the PDs, who have no obligation to agree to create or redeem Units on behalf of any investor and may impose terms and conditions in connection with such creation or redemption orders. Please refer to the Prospectus of the ETF for more details.  

Investments are subject to investment risks including the possible loss of the principal amount invested. The purchase of a unit in a fund is not the same as placing your money on deposit with a bank or deposit-taking company. There is no guarantee as to the amount of capital invested or return received. The value of the units and the income accruing to the units may fall or rise. Past performance is not necessarily indicative of the future or likely performance of the Products. There can be no assurance that investment objectives will be achieved.  

Where applicable, fund(s) may invest in financial derivatives and/or participate in securities lending and repurchase transactions for the purpose of hedging and/or efficient portfolio management, subject to the relevant regulatory requirements. PCM reserves the discretion to determine if currency exposure should be hedged actively, passively or not at all, in the best interest of the Products.  

The regular dividend distributions, out of either income and/or capital, are not guaranteed and subject to PCM’s discretion. Past payout yields and payments do not represent future payout yields and payments. Such dividend distributions will reduce the available capital for reinvestment and may result in an immediate decrease in the net asset value (“NAV”) of the Products. Please refer to <www.phillipfunds.com> for more information in relation to the dividend distributions.  

The information provided herein may be obtained or compiled from public and/or third party sources that PCM has no reason to believe are unreliable. Any opinion or view herein is an expression of belief of the individual author or the indicated source (as applicable) only. PCM makes no representation or warranty that such information is accurate, complete, verified or should be relied upon as such. The information does not constitute, and should not be used as a substitute for tax, legal or investment advice.  

The information herein are not for any person in any jurisdiction or country where such distribution or availability for use would contravene any applicable law or regulation or would subject PCM to any registration or licensing requirement in such jurisdiction or country. The Products is not offered to U.S. Persons. PhillipCapital Group of Companies, including PCM, their affiliates and/or their officers, directors and/or employees may own or have positions in the Products. Any member of the PhillipCapital Group of Companies may have acted upon or used the information, analyses and opinions herein before they have been published. 

This advertisement has not been reviewed by the Monetary Authority of Singapore.  

 

Phillip Capital Management (S) Ltd (Co. Reg. No. 199905233W)  
250 North Bridge Road #06-00, Raffles City Tower ,Singapore 179101 
Tel: (65) 6230 8133 Fax: (65) 65383066 www.phillipfunds.com